Brainsway Financials

BWAY Stock  ILA 1,746  43.00  2.52%   
We suggest to use Brainsway fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Brainsway is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze twenty-nine available fundamental indicators for Brainsway, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Brainsway to be traded at 2095.2 in 90 days.
  
Understanding current and past Brainsway Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brainsway's financial statements are interrelated, with each one affecting the others. For example, an increase in Brainsway's assets may result in an increase in income on the income statement.
Please note, the presentation of Brainsway's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brainsway's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Brainsway's management manipulating its earnings.

Brainsway Stock Summary

Brainsway competes with Intercure, Sofwave Medical, Epitomee Medical, Bio View, and Elbit Imaging. Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people.
Foreign Associate
  USA
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
ISINIL0011007189
Business Address19 Hartum Street,
SectorHealthcare
IndustryMedical Devices
BenchmarkDow Jones Industrial
Websitewww.brainsway.com
Phone(972) 2 582 4030
CurrencyILA
You should never invest in Brainsway without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Brainsway Stock, because this is throwing your money away. Analyzing the key information contained in Brainsway's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Brainsway Key Financial Ratios

Brainsway's financial ratios allow both analysts and investors to convert raw data from Brainsway's financial statements into concise, actionable information that can be used to evaluate the performance of Brainsway over time and compare it to other companies across industries.

Brainsway Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Brainsway's current stock value. Our valuation model uses many indicators to compare Brainsway value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainsway competition to find correlations between indicators driving Brainsway's intrinsic value. More Info.
Brainsway is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Brainsway by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brainsway's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Brainsway Systematic Risk

Brainsway's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brainsway volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Brainsway correlated with the market. If Beta is less than 0 Brainsway generally moves in the opposite direction as compared to the market. If Brainsway Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brainsway is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brainsway is generally in the same direction as the market. If Beta > 1 Brainsway moves generally in the same direction as, but more than the movement of the benchmark.

Brainsway December 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Brainsway help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brainsway. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brainsway based on widely used predictive technical indicators. In general, we focus on analyzing Brainsway Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brainsway's daily price indicators and compare them against related drivers.

Complementary Tools for Brainsway Stock analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.